Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also ...

The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...

The global anemia treatment market is on a steady growth path, with sales expected to exceed USD 10.0 billion in 2022.

Patients with symptomatic anaemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also receive vadadustat ...

Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also receive vadadustat instead of an erythropoiesis-stimulating agent such ...

including sickle cell disease and glucose-6-phosphate dehydrogenase deficiency. Lastly, a practical approach to the diagnosis of chronic anemia is presented. Anemia is defined as a condition in ...

The campaign aims to raise awareness about male anemia, its symptoms, and provides a self-test for iron deficiency on ...

As previously communicated, the planned Phase IIa study will be conducted in two parts. Part 1 aims to establish dosage levels and safety of sevuparin through single doses in 25-30 patients with ...

Bengaluru, November 19, 2024 –Emcure Pharmaceuticals Ltd., a leading Indian pharmaceutical company, launched a nationwide public awareness campaign t ...

Iron deficiency can cause several symptoms, including fatigue, headaches, and brittle nails. Spotting these signs early on can help you prevent complications.

Purpose The evidence evaluating the efficacy of i.v. versus oral iron for the treatment of iron deficiency in non-hemodialysis-dependent patients with chronic kidney disease (CKD) is reviewed.